Stocks
Amicus Therapeutics (FOLD) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.21 | -0.79 | -1.73 | 6.59 | 3.53 | 3.53 | |||
| Changes by years, y/y, % | +22% | -480% | +117% | -482% | -46% | +83.2% | |||
Amicus Therapeutics. Debt/EBITDA
Amicus Therapeutics. Debt/EBITDA, changes, %
Amicus Therapeutics (FOLD) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | 6.59 | 3.60 | 6.42 | 3.02 | 3.53 | 3.53 | ||
| Changes by years, y/y, % | -482% | -242% | -241% | -114% | -46% | |||
| Changes by quarters, q/q, % | -131% | -45% | +79% | -53% | +17% | |||
